Evolent Announces Third Quarter 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Evolent Health (EVH) Tops Q3 EPS by 23c; Offers FY23 Revenue Guidance
November 2, 2023 4:45 PM EDTEvolent Health (NYSE: EVH) reported Q3 EPS of $0.30, $0.23 better than the analyst estimate of $0.07. Revenue for the quarter came in at $511 million versus the consensus estimate of $509.21 million.
GUIDANCE:
Evolent Health sees FY2023 revenue of $1.95-1.97 billion, versus the consensus of... More
